Literature DB >> 11739312

Role for sulfatides in platelet aggregation.

M Merten1, P Thiagarajan.   

Abstract

BACKGROUND: Sulfatides are sulfated glycosphingolipids present on the surface of oligodendrocytes, renal tubular cells, and certain tumor cells. They appear to be involved in nerve conduction and cell adhesion, but their precise physiological function is not known. METHODS AND
RESULTS: Here, we show a novel role for sulfatides as a major ligand for P-selectin in platelet adhesion and aggregation. Sulfatides are expressed on the platelet surface, and platelets expressing sulfatides adhere to P-selectin. Both sulfatide micelles and sulfatide-binding recombinant malaria circumsporozoite protein (MCSP) inhibit this adhesion. In parallel, platelets and CHO cells expressing P-selectin adhere to sulfatides, and anti-P-selectin antibodies inhibit this adhesion. Furthermore, both anti-P-selectin antibodies and sulfatide antagonist MCSP significantly reverse platelet aggregation induced by ADP, collagen, or thrombin receptor-activating peptide, suggesting that sulfatide-P-selectin interactions are necessary for the formation of stable platelet aggregates.
CONCLUSIONS: These results show that sulfatide interactions with P-selectin are important in platelet adhesion and platelet aggregation. The sulfatide interactions with P-selectin stabilize platelet aggregates, representing a new mechanism of platelet aggregation that may play a significant role in hemostasis and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739312     DOI: 10.1161/hc4901.100383

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

1.  Recombinant P-selectin glycoprotein-ligand-1 delays thrombin-induced platelet aggregation: a new role for P-selectin in early aggregation.

Authors:  Jean-François Théorêt; Wissam Chahrour; Daniel Yacoub; Yahye Merhi
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

2.  Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis.

Authors:  Takayuki Nakayama; Tadashi Matsushita; Koji Yamamoto; Noriko Mutsuga; Tetsuhito Kojima; Akira Katsumi; Norihiko Nakao; J Evan Sadler; Tomoki Naoe; Hidehiko Saito
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

Review 3.  ABO Blood Group as a Model for Platelet Glycan Modification in Arterial Thrombosis.

Authors:  Ming Zhong; Hanrui Zhang; John P Reilly; Jason D Chrisitie; Mayumi Ishihara; Tadahiro Kumagai; Parastoo Azadi; Muredach P Reilly
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

Review 4.  Role of sulfatide in normal and pathological cells and tissues.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  J Lipid Res       Date:  2012-05-22       Impact factor: 5.922

5.  Structure, sulfatide binding properties, and inhibition of platelet aggregation by a disabled-2 protein-derived peptide.

Authors:  Shuyan Xiao; John J Charonko; Xiangping Fu; Alireza Salmanzadeh; Rafael V Davalos; Pavlos P Vlachos; Carla V Finkielstein; Daniel G S Capelluto
Journal:  J Biol Chem       Date:  2012-09-13       Impact factor: 5.157

6.  Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.

Authors:  Yuji Kamijo; Lixuan Wang; Akihiro Matsumoto; Takero Nakajima; Koji Hashimoto; Makoto Higuchi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Clin Exp Nephrol       Date:  2012-05-03       Impact factor: 2.801

7.  Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

Authors:  Mark Wahrenbrock; Lubor Borsig; Dzung Le; Nissi Varki; Ajit Varki
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 8.  Sphingolipid therapy in myocardial ischemia-reperfusion injury.

Authors:  Susheel Gundewar; David J Lefer
Journal:  Biochim Biophys Acta       Date:  2007-09-06

9.  Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure.

Authors:  Rui Hu; Gang Li; Yuji Kamijo; Toshifumi Aoyama; Takero Nakajima; Teruo Inoue; Koichi Node; Reiji Kannagi; Mamoru Kyogashima; Atsushi Hara
Journal:  Glycoconj J       Date:  2007-07-27       Impact factor: 2.916

10.  Sulfatides partition disabled-2 in response to platelet activation.

Authors:  Karen E Drahos; John D Welsh; Carla V Finkielstein; Daniel G S Capelluto
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.